European regulators advanced several new medicines, including a combined flu and COVID vaccine and new treatments for rare diseases.

The pending resolution "provides certainty going forward for Moderna's full infectious-disease portfolio," the company said, including its newer COVID vaccine, its combination COVID-and-flu shot, and ...

It's not COVID-19 or the flu, but a respiratory virus has been hammering Northern California cities, including Sacramento and ...

According to Dr. Pinsky, "If you think you may have cold symptoms and aren't sure if it's allergies, it's best to cover your ...

Moderna stock is rising after the company agreed to pay up to $2.25 billion to settle a patent dispute over technology used ...

Scientists in the United States say they may be inching closer to a long-sought goal in medicine: a single vaccine capable of protecting against multiple respiratory threats, from COVID-19 and the flu ...

Moderna agreed to pay up to $2.25 billion to settle a long‑running COVID vaccine patent dispute. The deal ends years of legal ...

About four years after the case was filed—and against the backdrop of a significantly changed COVID-19 vaccine ...

The group that makes recommendations on preventive health care services has not met in a year, and this latest meeting has not been rescheduled. Meanwhile, the Camp East Montana immigration facility ...

The settlement, which requires Moderna to pay the plaintiffs $950 million upfront plus up to $1.3 billion in contingent commitments, is an outcome “better than feared,” according to analysts.

Researchers at University California San Diego School of Medicine have found that a natural fungal supplement taken at the ...

Flu has overtaken covid in infections and hospitalizations during the winter respiratory virus season, and their virulence is ...